Abstract
Introduction Tuberculosis (TB) is the leading cause of death due to infectious disease worldwide. Social protection interventions can benefit TB-affected households. We conducted a systematic review and meta-analysis to quantify the effectiveness of social protection on TB treatment and socioeconomic outcomes.
Methods We identified articles published from January 2012 to July 2024 by searching PubMed (includes MEDLINE), Embase, and Web of Science. We included studies that described at least one social protection intervention and reported on either TB treatment or socioeconomic outcomes for people with TB or TB-affected households. Random-effects meta-analysis was used for our primary outcome of interest, TB treatment success (treatment completion or cure). We performed a meta-regression to evaluate the association of study characteristics with odds of TB treatment success. Risk of bias was assessed using the Newcastle Ottawa Scale and the Cochrane Risk of Bias tool. This review was registered prospectively in the PROSPERO database (registration number CRD42022382181).
Findings Our search generated 47,245 articles. Of the 50 which were eligible for inclusion, 36 reported TB treatment outcomes, 8 reported on socioeconomic, and two studies reported both TB treatment and socioeconomic outcomes. Random-effects meta-analysis of 24 articles found that people with TB who received social protection interventions during treatment had 2.23 times the odds of TB treatment success (95% CI 1.82, 2.74, I2 93.8%).
Conclusion Social protection interventions significantly improve odds of TB treatment success. Outcomes and definitions used in our study have the potential to guide further research and implementation of social protection for TB-affected populations.
What is already known on this topic Several studies have found that social and financial interventions designed to mitigate socioeconomic risk and promote resiliency, termed social protection interventions, have the potential to improve treatment outcomes for tuberculosis (TB), including treatment completion and cure. Additionally, several studies have demonstrated that social protection interventions can improve socioeconomic outcomes among TB-affected households such as averting catastrophic costs and negative financial coping strategies.
What this study adds This is the first systematic review and meta-analysis that comprehensively evaluates the impact of TB specific and TB sensitive social protection interventions on both TB treatment and socioeconomic outcomes, thereby generating evidence on the ability of these interventions to curb the well-known cycle of TB disease and poverty. Through the use of an extensive list of search terms, expanded and systematic inclusion of outcomes of interest, and a focused definition of social protection interventions, our systematic review included the adequate number of high-quality studies needed to conduct a meta-analysis. Additionally, our systematic review evaluated implementation outcomes described in eligible studies which provides the basis for feasibility of these strategies in programmatic settings.
How this study might affect research, practice or policy Our study provides evidence that social protection interventions, when used in conjunction with standard biomedical treatment, have the potential to significantly improve TB treatment outcomes. This study fills an essential gap in existing synthesized evidence of the impact of social protection interventions on TB, socioeconomic, and implementation outcomes. Our findings also highlight the need for standardized definitions of social protection, as well as uniform reporting procedures, to better help evaluate the impact of social protection interventions for TB-affected individuals and households. Addressing these gaps provides scientific basis for meeting the commitments articulated in the 2023 United Nations General Assembly high level meeting for TB which calls for social protection for all individuals with TB.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this study comes from the Nina Ireland Program in Lung Health (PI: Shete, fund number 7710-138404-7504523-45). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
